Tower Research Capital (TRC)’s Imunon IMNN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.49K | Buy |
1,866
+1,815
| +3,559% | +$5.98K | ﹤0.01% | 4114 |
|
|
2025
Q4 | $194 | Sell |
51
-252
| -83% | -$1.08K | ﹤0.01% | 4995 |
|
|
2025
Q3 | $1.55K | Buy |
303
+3
| +1% | +$20 | ﹤0.01% | 4761 |
|
|
2025
Q2 | $3.13K | Sell |
300
-13
| -4% | -$178 | ﹤0.01% | 4546 |
|
|
2025
Q1 | $4.29K | Sell |
313
-60
| -16% | -$719 | ﹤0.01% | 4279 |
|
|
2024
Q4 | $4.62K | Sell |
373
-2
| -0.5% | -$23 | ﹤0.01% | 4433 |
|
|
2024
Q3 | $5.18K | Sell |
375
-267
| -42% | -$4.23K | ﹤0.01% | 4313 |
|
|
2024
Q2 | $9.71K | Buy |
642
+309
| +93% | +$5.44K | ﹤0.01% | 4216 |
|
|
2024
Q1 | $7.12K | Sell |
333
-301
| -47% | -$2.87K | ﹤0.01% | 4258 |
|
|
2023
Q4 | $5.62K | Sell |
634
-6
| -0.9% | -$73 | ﹤0.01% | 4821 |
|
|
2023
Q3 | $8.2K | Sell |
640
-5
| -0.8% | -$78 | ﹤0.01% | 4378 |
|
|
2023
Q2 | $10.8K | Buy |
645
+9
| +1% | +$149 | ﹤0.01% | 4054 |
|
|
2023
Q1 | $10K | Sell |
636
-97
| -13% | -$1.86K | ﹤0.01% | 4357 |
|
|
2022
Q4 | $12K | Buy |
733
+119
| +19% | +$2.29K | ﹤0.01% | 3717 |
|
|
2022
Q3 | $13K | Sell |
614
-405
| -40% | -$11.4K | ﹤0.01% | 4272 |
|
|
2022
Q2 | $25K | Buy |
1,019
+626
| +159% | +$22.9K | ﹤0.01% | 3557 |
|
|
2022
Q1 | $26K | Buy |
+393
| New | +$30.8K | ﹤0.01% | 3285 |
|
|
2021
Q4 | – | Sell |
-1
| Closed | – | – | 6338 |
|
|
2021
Q3 | $0 | Sell |
1
-38
| -97% | -$7.89K | ﹤0.01% | 5945 |
|
|
2021
Q2 | $10K | Buy |
39
+26
| +200% | +$6.15K | ﹤0.01% | 4387 |
|
|
2021
Q1 | $4K | Sell |
13
-166
| -93% | -$55.8K | ﹤0.01% | 4781 |
|
|
2020
Q4 | $25K | Buy |
179
+102
| +132% | +$12.2K | ﹤0.01% | 3720 |
|
|
2020
Q3 | $11K | Buy |
77
+68
| +756% | +$17.2K | ﹤0.01% | 4059 |
|
|
2020
Q2 | $6K | Buy |
+9
| New | +$3.9K | ﹤0.01% | 4215 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4677 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | -$3.8K | – | 4509 |
|
|
2015
Q4 | $3K | Buy |
+1
| New | +$5.13K | ﹤0.01% | 3451 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4355 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 4683 |
|
|
2015
Q1 | – | Hold |
0
| – | -$2K | – | 4650 |
|
|
2014
Q4 | – | Sell |
-1
| Closed | -$6.94K | – | 3340 |
|
|
2014
Q3 | $4K | Hold |
1
| – | – | ﹤0.01% | 3429 |
|
|
2014
Q2 | $7K | Hold |
1
| – | – | ﹤0.01% | 2615 |
|
|
2014
Q1 | $10K | Buy |
+1
| New | +$10.4K | ﹤0.01% | 2603 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 4011 |
|
|
2013
Q3 | – | Sell |
-2
| Closed | -$29.6K | – | 4112 |
|
|
2013
Q2 | $23K | Buy |
+2
| New | +$27.8K | ﹤0.01% | 1574 |
|
Other funds holding IMNN
AC
RCA
VCM
VFT
HF
SS
Tower Research Capital (TRC)'s IMNN Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Imunon (IMNN) stake by 3,559% in Q1 2026, buying an estimated $5.98K and bringing the position to 1,866 shares worth $5.49K. The position accounts for ﹤0.01% of the portfolio, ranked #4114.
Tower Research Capital (TRC) first reported a position in IMNN in Q2 2013 and has held it in 28 quarters since. The position peaked at $26K in Q1 2022. 19 funds tracked by Wall St. Rank hold IMNN as of Q1 2026.
- Tower Research Capital (TRC) held 1,866 shares of Imunon worth $5.49K as of Q1 2026.
- Tower Research Capital (TRC) bought 1,815 Imunon shares in Q1 2026, an estimated $5.98K.
- Imunon made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4114 holding.
- Tower Research Capital (TRC) first reported a position in Imunon in Q2 2013 and has held it in 28 quarters since.
- Tower Research Capital (TRC)'s Imunon position peaked at $26K in Q1 2022.
- 19 funds tracked by Wall St. Rank held Imunon as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.